Abstract
Hormonal contraceptives are among the most widely used reversible methods of preventing pregnancy. In 2002, oral contraceptive pills (OCPs) were the most popular contraceptive method, used by 11.6 million women in the USA [1]. Unfortunately, for methods such as OCPs, which depend on adherence in order to be effective, there is a large difference in failure rates between perfect use and typical use. For example, the first year failure rate for OCPs with perfect use is only 0.3%, but with typical use it is 8% [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mosher WD, Martinez GM, Chandra A, et al. Use of contraception and use of family planning services in the United States: 1982–2002. Adv Data. 2004;350:1–36.
Trussell J. Contraceptive efficacy. In: Hatcher RA TJ, Nelson AL, Cates W, Stewart FH, Kowal D, eds. Contraceptive technology. 19th Ed. New York, NY: Ardent Media; 2007:747–826.
Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38(2):90–96.
Rosenberg MJ, Waugh MS, Long S. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives. J Reprod Med. 1995;40(5):355–360.
Kost K, Landry DJ, Darroch JE. Predicting maternal behaviors during pregnancy: does intention status matter? Fam Plann Perspect. 1998;30(2):79–88.
Brown S, Eisenberg L. The best intentions: Unintended pregnancy and the well-being of children and families. Washington, DC: National Academy Press; 1995:50–90.
Trussell J. The cost of unintended pregnancy in the United States. Contraception. 2007;75(3):168–170.
Rosenberg MJ, Waugh MS, Burnhill MS. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation. Fam Plann Perspect. 1998;30(2):89–92, 104.
Schwartz JL, Creinin MD, Pymar HC, et al. Predicting risk of ovulation in new start oral contraceptive users. Obstet Gynecol. 2002;99(2):177–182.
Murphy PA, Brixner D. Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database. Contraception. 2008;77(4):257–263.
Nelson AL, Westhoff C, Schnare SM. Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation. Obstet Gynecol. 2008;112(4):782–787.
Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception. 1995;51(5):283–288.
Lei ZW, Wu SC, Garceau RJ, et al. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception. Contraception. 1996;53(6):357–361.
Davie JE, Walling MR, Mansour DJ, et al. Impact of patient counseling on acceptance of the levonorgestrel implant contraceptive in the United Kingdom. Clin Ther. 1996;18(1):150–159.
Westhoff CL, Heartwell S, Edwards S, et al. Oral contraceptive discontinuation: do side effects matter? Am J Obstet Gynecol. 2007;196(4):412, e411–416; discussion 412, e416–417.
Blanc AK, Curtis SL, Croft TN. Monitoring contraceptive continuation: links to fertility outcomes and quality of care. Stud Fam Plann. 2002;33(2):127–140.
World Health Organization. Selected practice recommendations for contraceptive use. 2nd Ed; 2004. Available at: http://www.who.int/reproductive-health/publications/spr/spr.pdf. Accessed January 15, 2009.
Gaudet LM, Kives S, Hahn PM, et al. What women believe about oral contraceptives and the effect of counseling. Contraception. 2004;69(1):31–36.
Little P, Griffin S, Kelly J, et al. Effect of educational leaflets and questions on knowledge of contraception in women taking the combined contraceptive pill: randomised controlled trial. Br Med J. 1998;316(7149):1948–1952.
Melnick AL, Rdesinski RE, Creach ED, et al. The influence of nurse home visits, including provision of 3 months of contraceptives and contraceptive counseling, on perceived barriers to contraceptive use and contraceptive use self-efficacy. Womens Health Issues. 2008;18(6):471–481.
Petersen R, Albright J, Garrett JM, et al. Pregnancy and STD prevention counseling using an adaptation of motivational interviewing: a randomized controlled trial. Perspect Sex Reprod Health. 2007;39(1):21–28.
Peipert JF, Redding CA, Blume JD, et al. Tailored intervention to increase dual-contraceptive method use: a randomized trial to reduce unintended pregnancies and sexually transmitted infections. Am J Obstet Gynecol. 2008;198(6):630, e631–e638.
Matteson KA, Peipert JF, Allsworth J, et al. Unplanned pregnancy: does past experience influence the use of a contraceptive method? Obstet Gynecol. 2006;107(1):121–127.
Boyer CB, Shafer MA, Shaffer RA, et al. Evaluation of a cognitive-behavioral, group, randomized controlled intervention trial to prevent sexually transmitted infections and unintended pregnancies in young women. Prev Med. 2005;40(4):420–431.
Winikoff B, Mensch B. Rethinking postpartum family planning. Stud Fam Plann. 1991;22(5):294–307.
Hiller JE, Griffith E, Jenner F. Education for contraceptive use by women after childbirth. Cochrane Database Syst Rev. 2002;3:CD001863.
Gilliam M, Knight S, McCarthy M, Jr. Success with oral contraceptives: a pilot study. Contraception. 2004;69(5):413–418.
Halpern V, Grimes DA, Lopez L, et al. Strategies to improve adherence and acceptability of hormonal methods for contraception. Cochrane Database Syst Rev. 2006;1:CD004317.
Guttmacher Institute. U.S. Teenage Pregnancy Statistics: National and State Trends and Trends by Race and Ethnicity. Updated September; 2006. New York, NY: The Alan Guttmacher Institute. Available at: http://www.guttmacher.org/pubs/2006/09/12/USTPstats.pdf. Accessed January 15, 2009.
Ventura SJ, Abma JC, Mosher WD, et al. Recent trends in teenage pregnancy in the United States, 1990–2002. Health E-Stats. Hyattsville, MD: National Center for Health Statistics. Available at: http://www.cdc.gov/nchs/data/hestat/teenpreg1990–2002/teenpreg1990–2002.htm.
Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2005. Natl Vital Stat Rep. 2006;55(11):1–18.
Singh S, Darroch JE. Adolescent pregnancy and childbearing: levels and trends in developed countries. Fam Plann Perspect. 2000;32(1):14–23.
Abma JC, Martinez GM, Mosher WD, et al. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2002. Vital Health Stat. 2004;23(24):1–48.
Darroch JE. Adolescent pregnancy trends and demographics. Curr Womens Health Rep. 2001;1(2):102–110.
Elfenbein DS, Felice ME. Adolescent pregnancy. Pediatr Clin North Am. 2003;50(4):781–800, viii.
Hoffman SD, Maynard RA. Kids having kids: Economic costs and social consequences of teen pregnancy. 2nd Ed. Washington, DC: Urban Institute; 2008.
Santelli JS, Lindberg LD, Finer LB, et al. Explaining recent declines in adolescent pregnancy in the United States: the contribution of abstinence and improved contraceptive use. Am J Public Health. 2007;97(1):150–156.
Zink TM, Shireman TI, Ho M, et al. High-risk teen compliance with prescription contraception: an analysis of Ohio Medicaid claims. J Pediatr Adolesc Gynecol. 2002;15(1):15–21.
O’Dell CM, Forke CM, Polaneczky MM, et al. Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents. Obstet Gynecol. 1998;91(4):609–614.
Kirby D. Effective approaches to reducing adolescent unprotected sex, pregnancy, and childbearing. J Sex Res. 2002;39(1):51–57.
DiCenso A, Guyatt G, Willan A, et al. Interventions to reduce unintended pregnancies among adolescents: systematic review of randomised controlled trials. Br Med J. 2002;324(7351):1426.
Philliber S, Kaye JW, Herrling S, et al. Preventing pregnancy and improving health care access among teenagers: an evaluation of the Children’s Aid Society-Carrera program. Perspect Sex Reprod Health. 2002;34(5):244–251.
Moos MK, Bartholomew NE, Lohr KN. Counseling in the clinical setting to prevent unintended pregnancy: an evidence-based research agenda. Contraception. 2003;67(2):115–132.
Harper C, Callegari L, Raine T, et al. Adolescent clinic visits for contraception: support from mothers, male partners and friends. Perspect Sex Reprod Health. 2004;36(1):20–26.
Thurman AR, Hammond N, Brown HE, et al. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch? J Pediatr Adolesc Gynecol. 2007;20(2):61–65.
Canto De Cetina TE, Canto P, Ordonez Luna M. Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate. Contraception. 2001;63(3):143–146.
Hubacher D, Goco N, Gonzalez B, et al. Factors affecting continuation rates of DMPA. Contraception. 1999;60(6):345–351.
Depot medroxyprogesterone acetate and bone effects. ACOG Committee Opinion No.415. American College of Obstetricians and Gynecologists. Obstet Gynecol 2008;112:727–730.
World Health Organization. Medical eligibility criteria for contraceptive use. 3rd Ed; 2004. Available at: http://www.who.int/reproductive-health/publications/mec/index.htm. Accessed December 31, 2008.
Intrauterine devices and adolescents. ACOG Committee Opinion No. 392. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110:1493–1495.
Farley TM, Rosenberg MJ, Rowe PJ, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet. 1992;339(8796):785–788.
Faundes A, Telles E, Cristofoletti ML, et al. The risk of inadvertent intrauterine device insertion in women carriers of endocervical Chlamydia trachomatis. Contraception. 1998;58(2):105–109.
Skjeldestad FE, Halvorsen LE, Kahn H, et al. IUD users in Norway are at low risk for genital C. trachomatis infection. Contraception. 1996;54(4):209–212.
Blum RW. Sexual health contraceptive needs of adolescents with chronic conditions. Arch Pediatr Adolesc Med. 1997;151(3):290–297.
Suris JC, Resnick MD, Cassuto N, et al. Sexual behavior of adolescents with chronic disease and disability. J Adolesc Health. 1996;19(2):124–131.
Kovacs AH, Harrison JL, Colman JM, et al. Pregnancy and contraception in congenital heart disease: what women are not told. J Am CollCardiol. 2008;52(7):577–578.
Sawyer SM, Phelan PD, Bowes G. Reproductive health in young women with cystic fibrosis: knowledge, behavior and attitudes. J Adolesc Health. 1995;17(1):46–50.
Rogers P, Mansour D, Mattinson A, et al. A collaborative clinic between contraception and sexual health services and an adult congenital heart disease clinic. J Fam Plann Reprod Health Care. 2007;33(1):17–21.
Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. J Am Med Assoc. 2006;295(13):1549–1555.
Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103(2):219–224.
Weiss JL, Malone FD, Emig D, et al. Obesity, obstetric complications and cesarean delivery rate – a population-based screening study. Am J Obstet Gynecol. 2004;190(4):1091–1097.
Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metabol Disord. 2001;25(8):1175–1182.
Young TK, Woodmansee B. Factors that are associated with cesarean delivery in a large private practice: the importance of prepregnancy body mass index and weight gain. Am J Obstet Gynecol. 2002;187(2):312–318; discussion 318–320.
Kaneshiro B, Edelman A, Carlson N, et al. The relationship between body mass index and unintended pregnancy: results from the 2002 National Survey of Family Growth. Contraception. 2008;77(4):234–238.
Huber LR, Hogue CJ, Stein AD, et al. Contraceptive use and discontinuation: findings from the contraceptive history, initiation, and choice study. Am J Obstet Gynecol. 2006;194(5):1290–1295.
Chuang CH, Chase GA, Bensyl DM, et al. Contraceptive use by diabetic and obese women. Womens Health Issues. 2005;15(4):167–173.
Chin JR, Swamy GK, Ostbye T, Bastian LA. Contraceptive use by obese women one year postpartum. Contraception. 2009;80(5):463–468.
Kaneshiro B, Jensen JT, Carlson NE, et al. Body mass index and sexual behavior. Obstet Gynecol. 2008;112(3):586–592.
Ramlau-Hansen CH, Thulstrup AM, Nohr EA, et al. Subfecundity in overweight and obese couples. Hum Reprod. 2007;22(6):1634–1637.
Holing EV, Beyer CS, Brown ZA, et al. Why don’t women with diabetes plan their pregnancies? Diab Care. 1998;21(6):889–895.
St James PJ, Younger MD, Hamilton BD, et al. Unplanned pregnancies in young women with diabetes. An analysis of psychosocial factors. Diab Care. 1993;16(12):1572–1578.
Gu S, Sivin I, Du M, et al. Effectiveness of Norplant implants through seven years: a large-scale study in China. Contraception. 1995;52(2):99–103.
Grubb GS, Moore D, Anderson NG. Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries’ experience. Contraception. 1995;52(5):287–296.
Zieman M, Guillebaud J, Weisberg E, et al. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril. 2002;77(2 Suppl 2):S13–S18.
Holt VL, Scholes D, Wicklund KG, et al. Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol. 2005;105(1):46–52.
Holt VL, Cushing-Haugen KL, Daling JR. Body weight and risk of oral contraceptive failure. Obstet Gynecol. 2002;99(5 Pt 1):820–827.
Vessey M. Oral contraceptive failures and body weight: findings in a large cohort study. J Fam Plann Reprod Health Care. 2001;27(2):90–91.
Brunner Huber LR, Hogue CJ, Stein AD, et al. Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina. Ann Epidemiol. 2006;16(8):637–643.
Brunner Huber LR, Hogue CJ. The association between body weight, unintended pregnancy resulting in a livebirth, and contraception at the time of conception. Matern Child Health J. 2005;9(4):413–420.
Brunner Huber LR, Toth JL. Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth. Am J Epidemiol. 2007;166(11):1306–1311.
Jain J, Dutton C, Nicosia A, et al. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera. Contraception. 2004;70(1):11–18.
Grimes DA, Shields WC. Family planning for obese women: challenges and opportunities. Contraception. 2005;72(1):1–4.
Bonny AE, Ziegler J, Harvey R, et al. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med. 2006;160(1):40–45.
Hubacher D, Grimes DA. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv. 2002;57(2):120–128.
Samuelsson E, Hagg S. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users. Acta Obstet Gynecol Scand. 2004;83(7):674–681.
Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000;160(22):3415–3420.
Nightingale AL, Lawrenson RA, Simpson EL, et al. The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives. Eur J Contracept Reprod Health Care. 2000;5(4):265–274.
Mishell DR, Jr. Cardiovascular risks: perception versus reality. Contraception. 1999;59(1 Suppl):21S–24S.
Cardiovascular disease and steroid hormone contraception. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1998;877:i–vii, 1–89.
Narkiewicz K, Graniero GR, D’Este D, et al. Ambulatory blood pressure in mild hypertensive women taking oral contraceptives. A case-control study. Am J Hypertens. 1995;8(3):249–253.
Cardoso F, Polonia J, Santos A, et al. Low-dose oral contraceptives and 24-hour ambulatory blood pressure. Int J Gynecol Obstet. 1997;59(3):237–243.
Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO collaborative study of cardiovascular disease and steroid hormone contraception. Lancet. 1997;349(9060):1202–1209.
Schwartz SM, Petitti DB, Siscovick DS, et al. Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies. Stroke. 1998;29(11):2277–2284.
Use of hormonal contraception in women with coexisting medical conditions. ACOG Practice Bulletin No. 73. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2006;107:1453–1472.
Black HR, Leppert P, DeCherney A. The effect of medroxyprogesterone acetate on blood pressure. Int J Gynecol Obstet. 1978;17(1):83–87.
Taneepanichskul S, Reinprayoon D, Jaisamrarn U. Effects of DMPA on weight and blood pressure in long-term acceptors. Contraception. 1999;59(5):301–303.
Visser J, Snel M, Van Vliet HA. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2. Cochrane Database Syst Rev. 2006;4:CD003990.
Maggard MA, Yermilov I, Li Z, et al. Pregnancy and fertility following bariatric surgery: a systematic review. J Am Med Assoc. 2008;300(19):2286–2296.
Singh R, Frost J, Jordan B, et al. Beyond a prescription: strategies for improving contraceptive care. Contraception. 2009;79(1):1–4.
Stewart FH, Shields WC, Hwang AC. Title X: a sure-fire investment with at least a 300% return. Contraception. 2003;68(1):1.
Family Planning Services & Population Research Act. PLN 91-572. December 24; 1970.
Leeman L. Medical barriers to effective contraception. Obstet Gynecol Clin North Am. 2007;34(1):19–29, vii.
Larsen SB, Kragstrup J. Experiences of the first pelvic examination in a random samples of Danish teenagers. Acta Obstet Gynecol Scand. 1995;74(2):137–141.
Zabin LS, Emerson MR, Ringers PA, et al. Adolescents with negative pregnancy test results. An accessible at-risk group. J Am Med Assoc. 1996;275(2):113–117.
Harper C, Balistreri E, Boggess J, et al. Provision of hormonal contraceptives without a mandatory pelvic examination: the first stop demonstration project. Fam Plann Perspect. 2001;33(1):13–18.
Sawaya GF, Harper C, Balistreri E, et al. Cervical neoplasia risk in women provided hormonal contraception without a pap smear. Contraception. 2001;63(2):57–60.
Stewart FH, Harper CC, Ellertson CE, et al. Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence. J Am Med Assoc. 2001;285(17):2232–2239.
Lopez LM, Newmann SJ, Grimes DA, et al. Immediate start of hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2008;2:CD006260.
Rickert VI, Tiezzi L, Lipshutz J, et al. Depo now: preventing unintended pregnancies among adolescents and young adults. J Adolesc Health. 2007;40(1):22–28.
Guttmacher Institute. Emergency contraception. Available at: http://www.guttmacher.org/media/supp/ec121702.html. Accessed January 15; 2009.
Harper CC, Weiss DC, Speidel JJ, et al. Over-the-counter access to emergency contraception for teens. Contraception. 2008;77(4):230–233.
Raymond EG, Dalebout SM, Camp SI. Comprehension of a prototype over-the-counter label for an emergency contraceptive pill product. Obstet Gynecol. 2002;100(2):342–349.
Raymond EG, Chen PL, Dalebout SM. “Actual use” study of emergency contraceptive pills provided in a simulated over-the-counter manner. Obstet Gynecol. 2003;102(1):17–23.
Graham A, Moore L, Sharp D, et al. Improving teenagers’ knowledge of emergency contraception: cluster randomised controlled trial of a teacher led intervention. Br Med J. 2002;324(7347):1179.
Stewart HE, Gold MA, Parker AM. The impact of using emergency contraception on reproductive health outcomes: a retrospective review in an urban adolescent clinic. J Pediatr Adolesc Gynecol. 2003;16(5):313–318.
Golden NH, Seigel WM, Fisher M, et al. Emergency contraception: pediatricians’ knowledge, attitudes, and opinions. Pediatrics. 2001;107(2):287–292.
Raymond EG, Trussell J, Polis CB. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol. 2007;109(1):181–188.
Weaver MA, Raymond EG, Baecher L. Attitude and behavior effects in a randomized trial of increased access to emergency contraception. Obstet Gynecol. 2009;113(1):107–116.
Harper CC, Cheong M, Rocca CH, et al. The effect of increased access to emergency contraception among young adolescents. Obstet Gynecol. 2005;106(3):483–491.
Bearman P, Bruckner H. Promising the future: virginity pledges and the transition to first intercourse. Am J Sociol. 2001;106:859–912.
Trenholm C DB, Forston K, et al. Impacts of four Title V, Section 510 abstinence education programs. Princeton, NJ: Mathematica Research Group; 2007. Available at: http://aspe.hhs.gov/hsp/abstinence07/. Accessed December 31, 2008.
Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance – United States, 2007. Morb Mortal Wkly Rep, Surveil Summ. 2008;57(4):1–131.
Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect. 1998;30(1):24–29, 46.
Institute of Medicine. Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academy of Press; 2001.
Stewart M, Brown JB, Donner A, et al. The impact of patient-centered care on outcomes. J Fam Pract. 2000;49(9):796–804.
Kinnersley P, Stott N, Peters TJ, et al. The patient-centredness of consultations and outcome in primary care. Br J Gen Pract. 1999;49(446):711–716.
Cecil DW, Killeen I. Control, compliance, and satisfaction in the family practice encounter. Fam Med. 1997;29(9):653–657.
Rager KM, Omar HA. Hormonal contraception: noncontraceptive benefits and medical contraindications. Adolesc Med Clin. 2005;16(3):539–551.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Chin, J.R., Swamy, G.K., Floyd, S.E., Bastian, L.A. (2010). Hormonal Contraceptives and Adherence. In: Bosworth, H. (eds) Improving Patient Treatment Adherence. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5866-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5866-2_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5865-5
Online ISBN: 978-1-4419-5866-2
eBook Packages: MedicineMedicine (R0)